This website uses cookies to help you make the most of your visit.
By continuing to browse without changing your settings, you agree to our use of cookies.
Give me more information
x
-->

Pharmacy inspections

Inspection reports and learning from inspections

Skip to Content (Press Enter)

Famly and Friends Limited (1035903) - Improvement action plan

Standard not met Reason Action being taken by the Pharmacy By when Notification By Pharmacy Improvements Made
1.6

The pharmacy does not keep all the records it needs to by law. It still maintains some controlled drug records on photocopied controlled drug register sheets stapled together. It also doesn’t record all the necessary information required to comply with the law. Some responsible pharmacist (RP) records are incomplete and inaccurate. This means people can’t be certain who was in charge of the pharmacy at any given time.

All photocopied controlled drug (CD) register records have been fully transcribed into a compliant bound controlled drug register to ensure continuity, accuracy, and legal compliance. The photocopied records have been retained securely as historical records in line with legal requirements. The pharmacy now uses only the bound CD register for all current and future entries, with all required information recorded at the time of receipt or supply.
A reminder has been given to all pharmacists regarding their legal responsibilities for RP and CD record-keeping. A weekly audit of RP and CD records will be carried out by the Pharmacist/manager to monitor compliance and prevent recurrence.

11/02/2026
2.2

The pharmacy has not shown what training and supervision is being undertaken or has been completed by the person preparing multi-compartment compliance packs. This is to help make sure team members have the appropriate skills for their role.

The staff member involved in the preparation of multi-compartment compliance packs is already undertaking the role and is enrolled on the relevant training course. Evidence of enrolment and training is held within the pharmacy and has been provided for review

11/02/2026